Supernus Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Supernus Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Supernus Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Supernus Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Supernus Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US11833121B2 | Grant | Composition and method for treating neurological disease | A61K31/13; A61K45/06; A61K9/0004; A61K9/20; A61K9/2886; A61P25/16 | December 05, 2023 |
| US20230381191A1 | Application | Formulations of viloxazine | A61K31/5375; A61K9/00; A61K9/146; A61K9/2054; A61K9/485; A61K9/4866; A61K9/50 | November 30, 2023 |
| CA3126096C | Grant | Methods for producing viloxazine salts and novel polymorphs thereof | A61P13/00; A61P25/00; A61P25/20; A61P25/24; A61P25/26; A61P25/32; A61P7/12; C07C215/08; C07C217/34; C07D265/30; C07D265/32 | November 21, 2023 |
| US20230357173A1 | Application | Process of making derivatives of substituted morpholines | B01J2231/347; B01J2231/348; B01J2531/002; B01J31/0239; C07B2200/07; C07D265/30 | November 09, 2023 |
| US20230355589A1 | Application | Method of treatment of cns disorders | A61K31/00; A61K31/4188; A61K9/0053 | November 09, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer